A national audit of pancreatic enzyme prescribing in pancreatic cancer from 2015 to 2023 in England using OpenSAFELY-TPP

OBJECTIVES: Cancer treatments were variably disrupted during the COVID-19 pandemic. UK guidelines recommend pancreatic enzyme replacement therapy (PERT) to all people with unresectable pancreatic cancer. The aim was to investigate the impact of COVID-19 on PERT prescribing to people with unresectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemanska, Agnieszka, Andrews, Colm, Fisher, Louis, Butler-Cole, Ben, Mehrkar, Amir, Roberts, Keith J, Goldacre, Ben, Walker, Alex J, MacKenna, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460968/
https://www.ncbi.nlm.nih.gov/pubmed/36093352
http://dx.doi.org/10.1101/2022.07.08.22277317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460968/
https://www.ncbi.nlm.nih.gov/pubmed/36093352
http://dx.doi.org/10.1101/2022.07.08.22277317

Ejemplares similares